1Vote!
Medical News Today (Free subscription) | 07/17/2008
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of the Merlin™@home transmitter, an RF wireless technology that remotely monitors patients' implanted cardiac devices. The transmitter supports the St. Jude Medical Current® RF and Promote® RF family of devices and works in conjunction with the St. Jude Medical data management system, Merlin™.
+Vote!
Star Tribune (Free subscription) | 07/17/2008
St. Jude's results for the quarter, during which net income increased 48 percent, were "fantastic," Vaughn said. "They were very solid across the board." St. Jude reported double-digit revenue increases in all of its businesses -- even defibrillators, sales of which have slumped because of a series of industrywide safety recalls in the past two years.
+Vote!
The Minneapolis/St. Paul Business Journal (Free subscription) | 07/16/2008
Strong sales of products to treat heart problems lifted St. Jude Medical’s second quarter profits, which in turn sent the company’s shares upward. (STJ)
+Vote!
Business Week (Free subscription) | 07/16/2008
Analysts' opinions on stocks in the news Wednesday
+Vote!
Market Wire - Electronics and Semiconductors: Electronic Components (Free subscription) | 07/16/2008
OTTAWA, ONTARIO (MARKET WIRE) Zarlink Semiconductor Inc. (TSX: ZL)(NYSE: ZL) today announced that it is shipping production quantities of its ZL70101-based radio module to St. Jude Medical, a leading developer of medical technologies and services that treat cardiac, neurological and chronic pain patients worldwide.
+Vote!
Market Watch (Free subscription) | 07/16/2008
NEW YORK (MarketWatch) St. Jude Medical Inc. said Wednesday that second-quarter earnings were $201.1 million, or 58 cents a share, compared to $134.8 million in the same period a year ago. Sales were $1.14 billion, versus $947.3 million a year ago. Favorable foreign currency translation comparisons increased second-quarter sales by approximately $64 million. Reported net earnings for the period do...
+Vote!
The Earth Times Online Newspaper (Free subscription) | 07/16/2008
CHICAGO (Reuters) - St. Jude Medical Inc on Wednesday said quarterly earnings rose as sales of its implantable cardioverter defibrillators, or ICDs, rose 24 percent over a year ago.
+Vote!
Reuters (Free subscription) | 07/16/2008
CHICAGO (Reuters) - St. Jude Medical Inc on Wednesday said quarterly earnings rose as sales of its implantable cardioverter defibrillators, or ICDs, rose 24 percent over a year ago.
+Vote!
Red Orbit (Free subscription) | 07/15/2008
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of the Merlin(TM)@home transmitter, an RF wireless technology that remotely monitors patients' implanted cardiac devices. The transmitter supports the St.
+Vote!
Business Wire (Free subscription) | 07/15/2008
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of the Merlin™@home
+Vote!
Business Wire (Free subscription) | 07/10/2008
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced European CE Mark approval and European launch of its line of HydroSteer™